Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Octava revisión. Colima 2019


Por: Cárdenas-Sánchez J., Erazo Valle-Solís A.A., Arce-Salinas C., Bargalló-Rocha J.E., Bautista-Piña V., Cervantes-Sánchez G., Flores-Balcázar C.H., Lluch-Hernández A., Maffuz-Aziz A., Pérez-Sánchez V.M., Poitevin-Chacón A., Salas-González E., Torrecillas-Torres L., Valero-Castillo V.

Publicada: 1 ene 2019
Resumen:
Breast cancer is the most common neoplasm in women worldwide, as well as in our country. However, in Mexico there are differences that are important to identify and individualize in order to improve the outcomes of women suffering from this disease. Thus, the purpose of this 8th consensus review is to provide a national updated guideline, based on the best scientific evidence, and adjusted to the heterogeneity of our health system and to the existing needs and therapeutic coverage. Worldwide, breast cancer treatment is acknowledged as being multimodal, and therefore it requires a multidisciplinary group to help make the best therapeutic decisions. Hence, the conclusions of this consensus provide the best evidence to guide surgical, radiotherapy and systemic treatment, based on patient, tumor and the health system characteristics. Finally, in this edition, special emphasis is made on the need to establish an early and accurate diagnosis and to start the indicated therapy as soon as possible, since the delay in treatment implementation has been shown to negatively affect the survival rate. © 2018 Sociedad Mexicana de Oncología. Publicado por Permanyer México SA de CV.

Filiaciones:
Cárdenas-Sánchez J.:
 Instituto Estatal de Cancerología, Colima, Col., Mexico

Erazo Valle-Solís A.A.:
 Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico

Arce-Salinas C.:
 Instituto Nacional de Cancerología, SS Ciudad de México, Mexico

Bargalló-Rocha J.E.:
 Instituto Nacional de Cancerología, Ciudad de México, Mexico

Bautista-Piña V.:
 Instituto de Enfermedades de la Mama, FUCAM, Ciudad de México, Mexico

Cervantes-Sánchez G.:
 Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico

Flores-Balcázar C.H.:
 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico

Lluch-Hernández A.:
 Hospital Clínico Valencia, Spain

Maffuz-Aziz A.:
 Centro Médico ABC, Ciudad de México, Mexico

Pérez-Sánchez V.M.:
 Instituto Nacional de Cancerología, Ciudad de México, Mexico

Poitevin-Chacón A.:
 Médica sur, Ciudad de México, Mexico

Salas-González E.:
 Centro Médico de Occidente, IMSS Guadalajara, Jal., Mexico

Torrecillas-Torres L.:
 Centro Médico Nacional 20 de Noviembre, ISSSTE, Ciudad de México, Mexico

Valero-Castillo V.:
 Anderson Cancer Center, Houston, TX, United States
ISSN: 16659201
Editorial
Masson-Doyma Mexico, S.A., TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN, México
Tipo de documento: Article
Volumen: 18 Número: 3
Páginas: 141-231
WOS Id: 000590305700005

MÉTRICAS